Search for: "Alphapharm Pty. Ltd."
Results 1 - 20
of 49
Sort by Relevance
|
Sort by Date
30 Mar 2022, 4:31 am
Ltd [2022] FCAFC 39 (Ono) and Merck Sharp & Dohme Corp. v Sandoz Pty Ltd [2022] FCAFC 40 (MSD). [read post]
28 May 2016, 7:13 pm
These were succinctly summarised by Justice Beach in Streetworx Pty Ltd v Artcraft Urban Group Pty Ltd [2014] FCA 1366 (a decision that was upheld on appeal) in the form of three questions:What has the patentee promised for the invention as described in the relevant claim? [read post]
7 Nov 2014, 10:49 pm
The patent itself has already been found valid and infringed by a Full Bench of the Federal Court of Australia (in H Lundbeck A/S v Alphapharm Pty Ltd [2009] FCAFC 70), and all avenues of appeal from that decision have been exhausted. [read post]
4 May 2014, 3:14 am
Specifically, in AstraZeneca AB v Alphapharm Pty Ltd [2014] FCA 419, the patentee has been awarded a higher level of attorney fees under section 19 of the Patents Act, which relates to Certificates of Validity. [read post]
27 Apr 2014, 4:16 am
And, it seems, rightly so – because on 11 April 2014 the High Court of Australia granted ‘special leave’ (transcript at Alphapharm Pty Ltd v H Lundbeck A/S & Ors [2014] HCATrans 79), allowing generic manufacturer Alphapharm Pty Ltd to appeal the Federal Court decision.In fact, Alphapharm was only 50% successful in its bid. [read post]
28 Apr 2013, 8:08 am
Coincidentally, the High Court’s decision in Aktiebolaget Hässle v Alphapharm Pty Ltd [2002] HCA 59 is also the source of the current Australian law in relation to ‘obvious’ or ‘worthwhile’ to try (at paragraphs [66]-[76]). [read post]
21 Apr 2013, 1:42 am
The omeprazole case went on to become a leading authority on the law of inventive step in Australia, after it was successfully appealed by Astra to the High Court of Australia (Aktiebolaget Hässle v Alphapharm Pty Ltd [2002] HCA 59). [read post]
15 Feb 2013, 9:29 am
Alphapharm Pty., Ltd., 492 F.3d 1350, 1357 (Fed. [read post]
4 Sep 2012, 7:38 am
Alphapharm Pty., Ltd., 492 F.d 1350, 1357 (Fed. [read post]
7 May 2012, 10:51 am
Alphapharm Pty., Ltd., 492 F.3d 1350 (Fed. [read post]
11 Nov 2011, 5:18 am
Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth [2011] FCAFC 132 (28 October 2011) Appeal from: Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth Australia Pty Ltd [2010] FCA 1211 See also: Australian Federal Court Blocks Generic EFFEXOR-XR Validity – ‘external’ fair basis – whether claims entitled to priority date of original US application – whether claims are novel Generic pharmaceutical manufacturers Sigma… [read post]
15 Sep 2011, 5:46 am
The other defendants are sister companies, Alphapharm PTY Ltd. of Australia and Canada's Genpharm ULC, both accused of helping to run the scheme and manufacture or procure the medicines. [read post]
9 Sep 2011, 6:56 am
., along with Australia’s Alphapharm PTY Ltd. and Canada’s Genpharm ULC, “in a whistleblower lawsuit of scheming to overcharge the government by tens of millions of dollars for medicines. [read post]
9 Sep 2011, 6:13 am
They are Alphapharm Pty Ltd. in Australia and Genpharm ULC in Canada. [read post]
7 Sep 2011, 4:05 pm
The complaint alleges that Par Pharmaceuticals and two foreign companies - Alphapharm PTY Ltd. and Genpharm ULC - conspired with pharmacies to switch generic prescriptions to Par Pharmaceuticals’ generic version, allowing them to charge Medicaid higher prices. [read post]
15 Jun 2011, 4:56 am
(Patent Docs) Escitalopram – Australia: Patent office grants 121 month extension of time: Alphapharm Pty Ltd & Ors v H. [read post]
15 Feb 2011, 9:27 am
Michael Davitz, Partner at Axinn, Veltrop & Harkrider and Practice Center Contributor, recently sent in this article he wrote with colleague’s Drew Schulte and Jia Li discussing the Patent Prosecution Highway and the value that can be achieved for those practitioners willing to explore the new program. [read post]
24 Sep 2010, 1:15 pm
Alphapharm Pty., Ltd., 492 F.3d 1350 (Fed. [read post]
9 Sep 2010, 7:09 pm
Alphapharm Pty., Ltd., 492 F.3d 1350, 1356 (Fed. [read post]
2 Sep 2010, 10:51 am
Alphapharm Pty., Ltd., 492 F.3d 1350 (Fed. [read post]
